Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
BAHCESEHIR UNIVERSITESI currently has 2 pending office actions within the Transportation, E-Commerce & Mechanical Systems technology area. While there are 2 distinct examiners involved, the actions are housed within 1 distinct art unit, suggesting a consistent technical focus for these pending matters. This concentration in 1 art unit may allow for a more unified technical argument even as the company navigates the preferences of multiple examiners.
The busiest examiner, SHIAO, YIH-HORNG, is handling 1 pending office action. With a total of 2 pending office actions, the workload is split between different examiners. The fact that multiple examiners are operating within a single art unit provides an opportunity to compare examiner behaviors within the same technical group. Prosecution strategy should focus on resolving the pending actions by addressing the specific concerns of SHIAO, YIH-HORNG and the other assigned examiner to ensure consistent results across the portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.5% | +75.9% |
| OBAID, HAMZEH M | 1 | 38.3% | +22.4% |
| MYERS, CARLA J | 1 | 49.3% | +46.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 187d overdue |
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 26d overdue |
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 187d overdue |
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 26d overdue |
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | — |
| Art Unit | Apps |
|---|---|
| 3624 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | — | §102§103§112 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 3624 | §101§102 | Final Rejection | 26d overdue | Pending | Apr 25, 2024 |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 1682 | §102§112 | Final Rejection | 187d overdue | Pending | Aug 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial